Cardio-TriTest vs CVI42

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

CVI42

by Circle Cardiovascular Imaging Inc.

AI Verdict

Cardio-TriTest is a device-based solution for early and comprehensive cardiovascular disease detection by analyzing synchronized ECG, PCG, and MCG bio-signals, primarily for primary care. CVI42, conversely, is an AI-enabled software platform for advanced analysis of cardiac and vascular CT and MRI imaging, focusing on detailed diagnosis and treatment planning. While both serve cardiology, they utilize distinct diagnostic modalities and cater to different stages of patient assessment.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care clinic requires a non-invasive, device-based solution for early and comprehensive cardiovascular disease detection. This tool is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a holistic initial assessment directly in a clinical setting.

View Cardio-TriTest →

Choose CVI42 if…

Choose CVI42 if your cardiology or radiology department needs an advanced software platform for in-depth analysis of existing cardiac and vascular CT and MRI images. This solution is best suited for comprehensive plaque analysis, automated segmentation, and 3D visualization, enabling detailed diagnosis, treatment planning, and research for complex cardiovascular conditions.

View CVI42 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	CVI42
Pricing	Unknown	Starts at $5,000 per license.
Deployment	On-premise (device)	On-premise (standalone workstation or client/server)
FDA Status	Unknown	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardio-TriTest

Cardio-TriTest is a device-based, non-invasive tool designed for earlier and more comprehensive cardiovascular disease detection in primary care, making it accessible to a broader range of clinicians including general practitioners. Its focus on point-of-care insights suggests a simpler workflow compared to specialized imaging software. CVI42, while aiming for intuitive design, is an advanced software platform requiring qualified medical professionals experienced in cardiovascular MR or CT images.

Clinical Value

CVI42

While Cardio-TriTest offers significant value through early and comprehensive detection of common heart diseases in primary care, CVI42 provides a deeper, more specialized clinical value. CVI42 offers comprehensive cardiac and vascular imaging analysis, including AI-automated coronary plaque analysis, advanced CMR automation, and vascular CT tools, which are crucial for detailed diagnosis, planning, and patient care in complex cases for specialists.

Pricing & Value

CVI42

Both tools require contacting the vendor for pricing, limiting transparency. However, CVI42 explicitly mentions a 'flexible subscription that scales across CT and MR service lines' and modular licensing, which can offer better value by allowing organizations to pay only for needed features. Furthermore, information regarding CPT code 75577 for plaque analysis suggests a clear path to revenue generation and accelerated ROI for CVI42 users.

Enterprise Readiness

Cardio-TriTest

Cardio-TriTest explicitly states it is HIPAA compliant, a critical requirement for enterprise healthcare solutions. While CVI42 offers robust technical integration capabilities like DICOM and HL7 compatibility, client/server deployment, and secure connections, its HIPAA compliance and Business Associate Agreement (BAA) status are not disclosed in the provided facts, which would be a significant hurdle for enterprise adoption.

Innovation

CVI42

Both tools demonstrate innovation, with Cardio-TriTest integrating multiple bio-signals (ECG, PCG, MCG) for early detection in primary care. However, CVI42 showcases a broader and deeper range of cutting-edge AI applications in complex cardiac and vascular imaging analysis. Its features like AI-automated coronary lumen and wall segmentation, comprehensive plaque analysis, and advanced CMR automation represent more advanced innovation in specialized diagnostic capabilities.

Support & Docs

CVI42

CVI42 (Circle Cardiovascular Imaging) provides extensive and easily accessible documentation, including user manuals, installation guides, system requirements, and DICOM/HL7 conformance statements, along with a dedicated support team and high customer satisfaction scores. Information regarding explicit support and documentation for Cardio-TriTest (Cardio-HART) is much less detailed and harder to find through public searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	CVI42
Name	Cardio-TriTest	CVI42
Company	Cardio-Phoenix Inc.	CIRCLE CARDIOVASCULAR IMAGING
Primary Function	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection.	AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools.
Key Diagnostic Modalities/Input	ECG, PCG, MCG (3-in-1 device)	CT and MRI imaging data
AI-powered Analysis Focus	Synchronized bio-signal acquisition, visual correlation of heart bio-signals, and AI-powered analysis for heart disease detection.	AI-automated coronary lumen and wall segmentation, comprehensive coronary plaque analysis, advanced CMR automation, vascular CT analysis.
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Cardiothoracic Surgery, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and CVI42.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into existing clinical workflows for cardiovascular assessment, particularly differentiating between primary care diagnostics and advanced imaging analysis?

Cardio-TriTest is designed as a non-invasive, 3-in-1 diagnostic device (ECG, PCG, MCG) for earlier and more comprehensive cardiovascular disease detection in primary care settings. CVI42 is an AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools, primarily for specialized cardiology, cardiothoracic surgery, and radiology departments. CVI42 is engineered for workflow optimization, allowing cardiac teams to interpret studies faster with greater reproducibility and accuracy, and integrates seamlessly into existing CCTA workflows and PACS and reporting systems like PowerScribe One.

What specific metrics or clinical evidence support the accuracy and sensitivity of each tool in detecting and characterizing cardiovascular conditions, especially given their different diagnostic approaches?

Cardio-TriTest utilizes a unique combination of ECG, PCG, and MCG with AI-powered analysis to synchronize and visually correlate heart bio-signals for combined diagnostic purposes, aiding physicians in making a broader and more complete diagnosis of cardiovascular health. CVI42 focuses on AI-automated coronary lumen and wall segmentation and comprehensive plaque analysis from CT and MRI, along with advanced CMR automation, to provide detailed insights for diagnosis and planning, delivering fast, accurate, and reproducible results for quantifying total, calcified, and non-calcified plaque. Its AI algorithms are trained on diverse datasets and validated to ensure consistent results.

Considering Cardio-TriTest's primary care focus and CVI42's advanced imaging analysis, what is the expected learning curve for physicians in their respective specialties to achieve proficiency with each tool?

Cardio-TriTest, as a non-invasive diagnostic device for primary care, is likely designed for ease of use in a general clinical setting. CVI42, an advanced imaging analysis platform for cardiology, cardiothoracic surgery, and radiology, aims for workflow optimization and ease of use with clinically validated tools, but full standardization across cardiac imaging may involve adapting to new modules or modalities and rethinking reading lists. Studies on learning curves for medical imaging interpretation suggest that proficiency can be achieved after a certain number of cases, for example, around 30-50 cases for some interventional procedures or 50 readings for pre-TAVI cardiac CT analysis.

What is the depth of EHR integration offered by each tool, specifically regarding the seamless transfer of diagnostic results or imaging analysis reports into patient records?

Cardio-TriTest, as a diagnostic device, would need to integrate its 3-in-1 bio-signal analysis results into the EHR for patient records and longitudinal tracking. CVI42 offers simplified integrations with EMR, PACS/VNA, DICOM, and HL7 interfaces, and integrates directly into existing PACS and reporting systems like PowerScribe One, allowing for high-throughput analysis and reducing the time from 'scan to report'.

Beyond standard compliance, what audit-trail capabilities and enhanced security features does each tool offer to ensure data integrity, user accountability, and protection of sensitive patient information?

Cardio-TriTest, as a diagnostic device generating patient data, would require robust audit trails for diagnostic results and user actions to ensure data integrity and accountability. CVI42 processes imaging data locally within the customer's secure environment, with no data transmitted outside the institution, ensuring compliance with strict IT policies and data protection frameworks. Its AI models are 'frozen' and do not learn from customer data, ensuring consistent decisions and patient information protection within the facility's network.

What is the typical time-to-value for each tool, what level of ongoing support and training is provided, and are customer references available to demonstrate real-world clinical impact?

Cardio-TriTest, being a diagnostic device, may offer quicker initial time-to-value for basic diagnostic use in primary care, with support focused on device operation and maintenance. CVI42 aims to accelerate patient care with in-house plaque analysis enabling faster turnaround times and offers streamlined support with one vendor and one ticketing path. Circle CVI has a strong focus on customer satisfaction, with high CSAT and NPS scores, and customer testimonials highlighting speed, accuracy, optimized workflows, and great customer service.